블로그
-
Efficacy of Subsequent Treatments After Disease Progression on CDK4/6 Inhibitors in Patients ...
of Subsequent Treatments After Disease Progression on CDK4/6 Inhibitors in Patients With Hormone Receptor-Positive /human epidermal growth factor receptor 2-negative (HR+/HER2-) advanced breast cancer (aBC).
blog.naver.com · 2025.07.07
-
Dual targeting CDK4/6 and CDK7 augments tumor response and anti-tumor immunity in breast cancer...
Cyclin-dependent kinase 4/6 inhibitors (CDK4/6i) have transformed the treatment landscape for hormone receptor-positive Here, we demonstrate that dual inhibition of CDK4/6 and CDK7 is a promising strategy to overcome therapeutic
blog.naver.com · 2025.08.15
-
A Phase II Study of Fulvestrant plus Abemaciclib in Hormone Receptor–Positive Advanced or ...
Responses to endocrine monotherapy in advanced endometrial cancer are suboptimal, perhaps due to genomic alterations that promote estrogen receptor–independent cyclin D1–CDK4/6 activation.
blog.naver.com · 2025.06.04
-
Progression-Free Survival and Overall Survival of CDK 4/6 Inhibitors Plus Endocrine Therapy in ...
This meta-analysis of randomized controlled trials (RCTs) is aimed to better characterize the efficacy of CDK4/6 inhibitors in some relevant subgroups and to test heterogeneity between different co......
blog.naver.com · 2025.07.07
-
A Bayesian network meta-analysis of EGFR-tyrosine kinase inhibitor treatments in patients with ...
inhibitor treatments in patients with EGFR mutation-positive non-small cell lung cancer Background To date, no direct comparisons have been performed to compare the effectiveness of all epidermal growth
blog.naver.com · 2025.06.19
-
Nice paper in which they used EFT to develop a skin inflammation model to study diseases, psoriasis.
Nice paper in which they used EFT to develop a skin inflammation model to study diseases like psoriasis Key words: EpiDermFT, EFT-400, betamethasone, glucocorticoid, hyaluronic acid receptor, skin inflammation
blog.naver.com · 2025.06.12
-
Hormonal Therapy and Cardiovascular Health: Examining the Risk Among Premenopausal Women ...
risk alongside cancer itself.1 Women diagnosed with breast cancer face an increased risk for CVD due to comorbidities, and the cardiovascular effects of cancer treatments.1 Among patients diagnosed with hormone receptor–positive
blog.naver.com · 2025.06.20
-
Racial and ethnic disparities in the uptake of SGLT2is and GLP-1RAs among Medicare beneficiaries...
cardiovascular disease and chronic kidney disease, 2013–2019 Abstract Aims/hypothesis The aim of this study was to disparities in the use of sodium–glucose cotransporter 2 inhibitors (SGLT2is) and glucagon-like peptide-1 receptor
blog.naver.com · 2025.06.17
-
What effect have weight loss drugs had on the Scandinavian economy?
In less than a decade GLP-1 receptor agonists have transformed the treatment of obesity and made Novo This has lifted the drugs to blockbuster status, making the two developers Novo Nordisk and Eli Lilly
blog.naver.com · 2025.02.28
-
방학을 시작하며
One group was made intellectually superior by modifying the gene for the glutamate receptor. gene for the glutamate receptor.
blog.naver.com · 2024.07.23
